• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Infermedica Launches Ai Feature to Connect Patients with Specialists

Share:

December 9, 2020

The platform aims to significantly shorten the path from patient to medical specialist.

Poland-based AI platform for preliminary diagnosis, Infermedica has announced the launch of its new feature, Specialist Recommender.

The platform was developed over six months, in response to clients’ requests to provide patients with more tailored advice in addition to initial triaging suggestions.

The function enables healthcare and insurance providers to provide patients with a recommendation of specialists they need to see.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

WHY IT MATTERS

The function extends the recommendation of pre-clinical triage to a specific specialist, alongside the most effective communication channel to them. This creates direct integration with clients’ booking systems, enabling more streamlined medical care by shortening the path from patient and specialist.

Directing patients to the correct specialists prevents a backlog of patients in waiting rooms who do not need to be there, freeing up doctors to focus on those who need urgent care and consequently reducing costs for the healthcare system.

The function is supported by a list of 27 specialists – including pulmonologists, haematologists and allergologists – with providers able to select available options.

It is available in 18 languages and also includes regional differences in specialist accessibility, regulations, and clinical practices, ensuring patients receive appropriate instructions to take action.

Infermedica’s AI-driven platform is available via three interfaces:

  • A customisable API, which can be integrated into clients’ sites, websites and apps.
  • A white-label Symptom Checker that is available as a chatbot and voice assistant.
  • The Call Center Triage solution that enables telemedicine personnel to pre-diagnose patients and understand the severity of issues and receive timely assistance if needed.

THE LARGER CONTEXT

In August, Infermedica announced a $10.2 million (€8.4 million) Series A funding for its triage symptom checking system.

ON THE RECORD

Maciej Malenda, Infermedica’s head of partnerships, said: “This represents the next step in healthcare digitisation and Infermedica is pioneering the space. Our clients, which are predominantly healthcare and insurance providers, wanted to give patients more granular medical advice, so we moved quickly to develop the unique Specialist Recommender.

“A natural evolution of digital pre-diagnosis and triage processes, the feature will help quicken patient recovery by providing deeper, more tailored medical advice with direct instructions about who they need to see to help with a particular health issue. Our solutions continue to drive the industry forward through making healthcare more accessible and improving people’s lives for the better.”

Jakub Winter, Infermedica’s head of implementation, further explained: “The recommendation takes into consideration the patient profile, provided evidence, and its related severity. Analysing possible conditions and evidence allows us to see the big picture and provide a recommendation that is linked not only to the most likely outcome, but also the most serious scenarios. Consequently, the function is then able to guide patients to the experts who can expand the interview, run detailed diagnostics and initiate treatment.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Nextech Announces Acquisition of MyMedLeadsNextech announces acquisition of MyMedLeads expanding suite of patient engagement and marketing solutions for specialty practicesNextech Announces Acquisition of MyMedLeadsNextech announces acquisition of MyMedLeads expanding suite of patient engagement and marketing solutions for specialty practices
  • 59 Health Tech Companies Share Their 2017 Revenues To Land On Inc 5000 List59 Health Tech Companies Share Their 2017 Revenues To Land On Inc 5000 List
  • Mirus Capital Advisors Advises Mobilize RRS LLC In Its Acquisition By ZOLL Medical CorporationMirus Capital Advisors Advises Mobilize RRS LLC In Its Acquisition By ZOLL Medical Corporation
  • Revance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic PracticesRevance Announces Agreement to Acquire HintMD and its Proprietary Fintech Platform for Aesthetic Practices
  • Securing legacy medical devices is daunting – but not optionalSecuring legacy medical devices is daunting – but not optional
  • Amneal Completes Acquisition of Kashiv Specialty PharmaceuticalsAmneal Completes Acquisition of Kashiv Specialty Pharmaceuticals
  • Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral DrugsTonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
  • Orgenesis Announces Agreement for the Sale of Masthercell Global, Its Contract Development and Manufacturing Organization (CDMO) SubsidiaryOrgenesis Announces Agreement for the Sale of Masthercell Global, Its Contract Development and Manufacturing Organization (CDMO) Subsidiary

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications